Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis.

Literature DB >> 6024528

Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis.

J Houseley, J J Oppenheim.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 1967 PMID： 6024528 PMCID： PMC1842300 DOI： 10.1136/bmj.2.5553.679

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

× No keyword cloud information.

10 in total

1. IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES.

Authors: K HIRSCHHORN; R R SCHREIBMAN; F H BACH; L E SILTZBACH
Journal: Lancet Date: 1964-10-17 Impact factor: 79.321

2. AN IMMUNOLOGIC SURVEY OF FORTY-EIGHT PATIENTS WITH MYASTHENIA GRAVIS.

Authors: M M ADNER; J D SHERMAN; C ISE; R S SCHWAB; W DAMESHEK
Journal: N Engl J Med Date: 1964-12-24 Impact factor: 91.245

3. ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MYASTHENIA GRAVIS WHICH REACT WITH THERMALLY DENATURED DNA-COATED BENTONITE.

Authors: B C STURGILL; R R CARPENTER; A J STRAUSS; H C GOODMAN
Journal: Proc Soc Exp Biol Med Date: 1964-01

4. STUDIES IN MYASTHENIA GRAVIS. IMMUNOLOGIC RESPONSE IN THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS.

Authors: P KORNFELD; S SIEGAL; L B WEINER; K E OSSERMAN
Journal: Ann Intern Med Date: 1965-09 Impact factor: 25.391

5. The autoimmune response in myasthenia gravis.

Authors: R G WHITE; A H MARSHALL
Journal: Lancet Date: 1962-07-21 Impact factor: 79.321

6. Changes in serum complement activity in patients with myasthenia gravis.

Authors: W L NASTUK; O J PLESCIA; K E OSSERMAN
Journal: Proc Soc Exp Biol Med Date: 1960-10

7. AN IN VITRO SYSTEM FOR THE STUDY OF THE MECHANISM OF ANTIGENIC STIMULATION IN THE SECONDARY RESPONSE.

Authors: R W DUTTON; J D EADY
Journal: Immunology Date: 1964-01 Impact factor: 7.397

8. Studies in myasthenia gravis: immunofluorescent tagging of muscle striation with antibody from serums of 256 myasthenic patients.

Authors: K E Osserman; L B Weiner
Journal: Ann N Y Acad Sci Date: 1965-06-30 Impact factor: 5.691

9. Immunological concomitants of myasthenia gravis.

Authors: A J Strauss; H W van der Geld; P G Kemp; E D Exum; H C Goodman
Journal: Ann N Y Acad Sci Date: 1965-06-30 Impact factor: 5.691

10. Impaired in vitro lymphocyte transformation in patients with ataxia-telangiectasis.

Authors: J J Oppenheim; M Barlow; T A Waldmann; J B Block
Journal: Br Med J Date: 1966-08-06

10 in total

13 in total

Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis.

1. IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES.

2. AN IMMUNOLOGIC SURVEY OF FORTY-EIGHT PATIENTS WITH MYASTHENIA GRAVIS.

3. ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MYASTHENIA GRAVIS WHICH REACT WITH THERMALLY DENATURED DNA-COATED BENTONITE.

4. STUDIES IN MYASTHENIA GRAVIS. IMMUNOLOGIC RESPONSE IN THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS.

5. The autoimmune response in myasthenia gravis.

6. Changes in serum complement activity in patients with myasthenia gravis.

7. AN IN VITRO SYSTEM FOR THE STUDY OF THE MECHANISM OF ANTIGENIC STIMULATION IN THE SECONDARY RESPONSE.

8. Studies in myasthenia gravis: immunofluorescent tagging of muscle striation with antibody from serums of 256 myasthenic patients.

9. Immunological concomitants of myasthenia gravis.

10. Impaired in vitro lymphocyte transformation in patients with ataxia-telangiectasis.

1. Absence of cellular hypersensitivity to muscle and thymic antigens in myasthenia gravis.

2. Early-onset myasthenia gravis: clinical characteristics and response to therapy.

3. Immunologic response in vitro after thymechtomy in patients with myasthenia gravis.

Review 4. Cellular autoimmunity to muscle: a review.

5. Lymphocyte stimulation with muscle homogenate in polymyositis and other muscle-wasting disorders.

Review 6. Phenotypic and functional analysis of lymphocytes in myasthenia gravis.

7. Clinical and immunological associations in myasthenia gravis. 2. Cell-mediated immunity.

8. Lymphocyte function in myasthenia gravis.

9. The immunological effects of thymectomy in myasthenia gravis.

10. Leucocyte migration inhibition in myasthenia gravis. The effect of thymectomy.